Health Care and Pharmaceutical Industry

Masters
Research Proposal
Business
Pages 4 (1004 words)
Download 0
Consolidation of health care and pharmaceutical industry can not be confined to a single country or region as the very purpose of consolidation demands. Mergers and Acquisitions have been the order of the day for reasons of economy and competitive advantage…

Introduction

Hence consolidation can be in the form of merger between two or more pharmaceutical companies, acquisition of one pharmaceutical company by another, merger or acquisition between a formulations company and a bulk drugs company terming which as vertical integration will be more appropriate. There can also be mergers or acquisitions between a health care industry and a pharmaceutical industry, a form of vertical integration. All these activities centre around one goal, that is consolidation. The generic meaning of consolidation is strengthening. Hence consolidation is for obviously strengthening of merging entities. The question this proposal however poses is who the beneficiaries of the consolidation are. The stakeholders in the consolidation process are shareholders of the company, its consumers, its suppliers, its customers, its employees, Government and environmentalists. Apart from them, behind the scenes are the consultants and the directors of the company who manipulate consolidation. This proposal will undertake a detailed study as to who the real beneficiaries of consolidation are. This is the research question the proposed research will address for which purpose detailed literatures review will be undertaken.
The very question presupposes existence of a problem of who actually the beneficiaries are in consolidations. ...
Download paper
Not exactly what you need?

Related papers

The Global Pharmaceutical Industry: Swallowing a bitter pill' Case Study
Generally, the global pharmaceutical industry recovered after the World War II due to the stable economical, social, cultural, and political environment. During this period, immense R&D was attained, which has been very critical in enhancing effectiveness and efficiency in treating various diseases and ailments. Nonetheless, there have been many changes such as competition for patents and other…
Case: The Global Pharmaceutical Industry assignment two
547). The risky nature and lengthy R & D process was evaluated to be due to the average length in years (taking 10 to 15) that an experimental drug needs from its discovery up to clinical trials, FDA approval and finally post marketing tests before it could be safely marketed and distributed to the patients. High levels of risk could only be appropriately compensated by high costs which are…
Pharmaceutical Industry: New Prescription Drugs
The pricing for this patent is very steep but once the medication has patent protection, the company can exercise its ability to set its own medicine price, without consideration of a competitor (Wardell & Lasagna, p 35). With this monopoly, comes a lot of power which gives pharmaceutical companies the incentive to focus on the large amount of capital needed for research and development. This then…
The Global Pharmaceutical Industry
The global pharmaceutical industry has significantly contributed to the human civilization for the welfare of mankind. The study will describe how internal and external environment forces have affected the industry (Maclennan, 2004, p.11). In order to determine the issues, PESTEL Analysis and Porter’s Five Force Analysis have been implemented in the study. Finally, a strategic SWOT analysis has…
Case study "The global pharmaceutical industry"
It is expected that the pharmaceutical companies have the best potential to benefit from "aging population and increasing life expectancy rates throughout the world", the market for such products have expanded significantly, and it is predicted that by the end of current decade the concept of drugs for increase in life expectancy shall receive positive response in the poor countries of Asia and…
Health Care and Pharmaceutical Industry
Hence consolidation can be in the form of merger between two or more pharmaceutical companies, acquisition of one pharmaceutical company by another, merger or acquisition between a formulations company and a bulk drugs company terming which as vertical integration will be more appropriate. There can also be mergers or acquisitions between a health care industry and a pharmaceutical industry, a…
Business Risks in the Pharmaceutical Industry
Manufacturers of generic pharmaceutical products in countries like Asia and Latin America are challenging the company's patents and trademark protection.…